Literature DB >> 15596863

Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.

Aaron M Milstone1, JenniElizabeth Petrella, Melissa D Sanchez, Mariam Mahmud, J Charles Whitbeck, Jeffrey M Bergelson.   

Abstract

Although many coxsackie B viruses interact with decay accelerating factor (DAF), attachment to DAF by itself is not sufficient to initiate infection. We examined the early events in infection that follow virus interaction with DAF, and with the coxsackievirus and adenovirus receptor (CAR). Interaction with soluble CAR in a cell-free system, or with CAR on the surfaces of transfected cells, induced the formation of A particles; interaction with soluble or cell surface DAF did not. The results suggest that CAR, but not DAF, is capable of initiating the conformational changes in the viral capsid that lead to release of viral nucleic acid.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596863      PMCID: PMC538729          DOI: 10.1128/JVI.79.1.655-660.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.

Authors:  R M Powell; T Ward; D J Evans; J W Almond
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

2.  Evidence for the direct involvement of the rhinovirus canyon in receptor binding.

Authors:  R J Colonno; J H Condra; S Mizutani; P L Callahan; M E Davies; M A Murcko
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).

Authors:  T M Karnauchow; D L Tolson; B A Harrison; E Altman; D M Lublin; K Dimock
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Is the 135S poliovirus particle an intermediate during cell entry?

Authors:  Y Huang; J M Hogle; M Chow
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Expression and Purification of Secreted Forms of HSV Glycoproteins from Baculovirus-Infected Insect Cells.

Authors:  S H Willis; C Peng; M P Leon; A V Nicola; A H Rux; G H Cohen; R J Eisenberg
Journal:  Methods Mol Med       Date:  1998

6.  Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor.

Authors:  Y He; P R Chipman; J Howitt; C M Bator; M A Whitt; T S Baker; R J Kuhn; C W Anderson; P Freimuth; M G Rossmann
Journal:  Nat Struct Biol       Date:  2001-10

7.  Neutralization of poliovirus by cell receptors expressed in insect cells.

Authors:  G Kaplan; M S Freistadt; V R Racaniello
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

8.  Viral cell entry induced by cross-linked decay-accelerating factor.

Authors:  D R Shafren
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins.

Authors:  I W Caras; M A Davitz; L Rhee; G Weddell; D W Martin; V Nussenzweig
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

Review 10.  Viral cell recognition and entry.

Authors:  M G Rossmann
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

View more
  38 in total

1.  Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.

Authors:  Steven D Carson; Nora M Chapman; Susan Hafenstein; Steven Tracy
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Human enterovirus 71 uncoating captured at atomic resolution.

Authors:  Ke Lyu; Jie Ding; Jian-Feng Han; Yu Zhang; Xiao-Yan Wu; Ya-Ling He; Cheng-Feng Qin; Rong Chen
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 3.  Is a multivalent hand, foot, and mouth disease vaccine feasible?

Authors:  Michel Klein; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015-05-26       Impact factor: 3.452

4.  Molecular determinants of disease in coxsackievirus B1 murine infection.

Authors:  Javier O Cifuente; María F Ferrer; Carolina Jaquenod de Giusti; Wen-Chao Song; Víctor Romanowski; Susan L Hafenstein; Ricardo M Gómez
Journal:  J Med Virol       Date:  2011-09       Impact factor: 2.327

5.  Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor.

Authors:  Jieyan Pan; Bhargavi Narayanan; Shardule Shah; Joshua D Yoder; Javier O Cifuente; Susan Hafenstein; Jeffrey M Bergelson
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

6.  Early Entry Events in Echovirus 30 Infection.

Authors:  Helena Vandesande; Mira Laajala; Tino Kantoluoto; Visa Ruokolainen; A Michael Lindberg; Varpu Marjomäki
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

7.  Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2.

Authors:  Carolyn B Coyne; Kwang S Kim; Jeffrey M Bergelson
Journal:  EMBO J       Date:  2007-08-23       Impact factor: 11.598

8.  Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins.

Authors:  Paula Turkki; Mira Laajala; Marie Stark; Helena Vandesande; Heidi Sallinen-Dal Maso; Sailee Shroff; Anna Sävneby; Ganna Galitska; A Michael Lindberg; Varpu Marjomäki
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

9.  Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells.

Authors:  Kunal P Patel; Carolyn B Coyne; Jeffrey M Bergelson
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

10.  A rapid and efficient method for studies of virus interaction at the host cell surface using enteroviruses and real-time PCR.

Authors:  Nina Jonsson; Maria Gullberg; Stina Israelsson; A Michael Lindberg
Journal:  Virol J       Date:  2009-12-07       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.